Sarah Mellor Name match only — unverified

Consultant · activity score 101

101 IND-paid disbursements
$346,653
paid as individual · 1 payer
7y
activity span (2020-2026)

Activity over time 7 year span

2020: 0 committee · 0 candidate · 31 IND-paid ($44K)20202021: 0 committee · 0 candidate · 40 IND-paid ($52K)20212022: 0 committee · 0 candidate · 30 IND-paid ($74K)20222023: 0 committee · 0 candidate · 30 IND-paid ($65K)20232024: 0 committee · 0 candidate · 26 IND-paid ($77K)20242025: 0 committee · 0 candidate · 15 IND-paid ($34K)20252026: 0 committee · 0 candidate · 1 IND-paid ($0K)2026
Committee-officer role Candidate filing IND-paid disbursement

Top payers 1 committee · $346,653 total

Committee Payments Total
ACTBLUE 173 $346,653

Aggregated across all Schedule B IND payments to this name. Color: derived partisan lean of the paying committee (direct party_affiliation OR committee_partisan_lean.lean_score for super PACs).

Recent payments to this name last 20 · $55,621

DatePayerPurposeAmount
Jan 20, 2026 ACTBLUE PER DIEM $215
Jun 20, 2025 ACTBLUE SALARY $2,666
Jun 6, 2025 ACTBLUE SALARY $2,566
May 23, 2025 ACTBLUE SALARY $2,666
May 9, 2025 ACTBLUE SALARY $2,566
Apr 25, 2025 ACTBLUE SALARY $2,666
Apr 11, 2025 ACTBLUE SALARY $2,513
Mar 31, 2025 ACTBLUE SALARY $8
Mar 28, 2025 ACTBLUE SALARY $2,605
Mar 14, 2025 ACTBLUE SALARY $2,513
Feb 28, 2025 ACTBLUE SALARY $2,613
Feb 14, 2025 ACTBLUE SALARY $2,513
Jan 31, 2025 ACTBLUE SALARY $2,601
Jan 24, 2025 ACTBLUE PER DIEM $129
Jan 17, 2025 ACTBLUE SALARY $2,611
Jan 3, 2025 ACTBLUE SALARY $2,511
Dec 20, 2024 ACTBLUE SALARY $2,611
Dec 6, 2024 ACTBLUE SALARY $13,925
Nov 22, 2024 ACTBLUE SALARY $2,611
Nov 8, 2024 ACTBLUE SALARY $2,511

Disbursement rows where this name appears as the payee (schedule_b entity_tp='IND'). Name-matched, not identity-resolved — may include same-named individuals.

Geographic concentration 1 state

MA
1 payer cmte

Composite of candidate filings (cand.state) + states of distinct payer committees. Surfaces where the operative is geographically active.